Hollysys said it received a bid of $23 cash a share from a group including its founder. That tops a $17.10-a-share proposal from another group.

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Camping World's revenue jumped 28% to $2.06 billion in the second quarter but trailed analysts’ consensus estimate.

Outlook Therapeutics plans to submit an application to the Food and Drug Administration.

Fidelity National Information Services raised its guidance for the second time this year, but third-quarter expectations are below analyst estimates.

Nvidia 'continues to execute across all segments,' J.P. Morgan analyst Harlan Sur said, lifting his price target to $215 from $176.

Private-equity icon KKR reported second-quarter earnings beat Wall Street estimates and asset inflows touched a record.

J. Allen Brack is leaving Blizzard 'to pursue new opportunities,' the company says.

Jim Cramer discusses COVID market sentiment, Under Armour, BP, DuPont, Eli Lilly and more in Tuesday's video interview with TheStreet Live.

Corsair Gaming shares fell after the videogame-equipment company reported weaker-than-expected second-quarter earnings.